For example, through taking advantage of the adjuvant capacity of Mincle agonist, conjugating model antigen with Mincle agonist is a new pathway to develop cancer vaccines, which has been proven to provoke strong anti-tumor immune responses in mice (196). This evidence concerns the gene CLEC4E and neoplasm.